2019 annual financial data
4D Molecular Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -525.49%.
Operating income was -50,764,000 USD and net income was -49,306,000 USD.
Operating cash flow was -36,711,000 USD.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,986,000 USD
- Operating income
- -50,764,000 USD
- Net income
- -49,306,000 USD
- Operating cash flow
- -36,711,000 USD